- Home
- RPRX vs FSLR Comparison
RPRX vs FSLR Comparison
Compare RPRX & FSLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- FSLR
- Stock Information
- Founded
- RPRX 1996
- FSLR 1999
- Country
- RPRX United States
- FSLR United States
- Employees
- RPRX N/A
- FSLR N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- FSLR Semiconductors
- Sector
- RPRX Health Care
- FSLR Technology
- Exchange
- RPRX Nasdaq
- FSLR Nasdaq
- Market Cap
- RPRX 14.2B
- FSLR 13.1B
- IPO Year
- RPRX 2020
- FSLR 2006
- Fundamental
- Price
- RPRX $33.10
- FSLR $133.76
- Analyst Decision
- RPRX Strong Buy
- FSLR Strong Buy
- Analyst Count
- RPRX 4
- FSLR 29
- Target Price
- RPRX $42.50
- FSLR $230.11
- AVG Volume (30 Days)
- RPRX 3.9M
- FSLR 3.9M
- Earning Date
- RPRX 05-08-2025
- FSLR 04-29-2025
- Dividend Yield
- RPRX 2.66%
- FSLR N/A
- EPS Growth
- RPRX 37.42
- FSLR 23.43
- EPS
- RPRX 2.45
- FSLR 11.77
- Revenue
- RPRX $2,263,576,000.00
- FSLR $4,256,749,000.00
- Revenue This Year
- RPRX $31.30
- FSLR $32.44
- Revenue Next Year
- RPRX $5.82
- FSLR $20.21
- P/E Ratio
- RPRX $13.52
- FSLR $11.36
- Revenue Growth
- RPRX 1.12
- FSLR 19.42
- 52 Week Low
- RPRX $24.05
- FSLR $116.56
- 52 Week High
- RPRX $34.20
- FSLR $306.77
- Technical
- Relative Strength Index (RSI)
- RPRX 57.01
- FSLR 52.28
- Support Level
- RPRX $31.97
- FSLR $125.80
- Resistance Level
- RPRX $33.00
- FSLR $130.79
- Average True Range (ATR)
- RPRX 0.71
- FSLR 6.80
- MACD
- RPRX 0.08
- FSLR 0.20
- Stochastic Oscillator
- RPRX 60.08
- FSLR 57.44
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About FSLR First Solar Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.